AMMAN —
His Majesty King Abdullah on Tuesday
inaugurated Hikma Pharmaceuticals’ new Middle East and North Africa (MENA)
headquarters in Amman, a Royal Court statement said.
اضافة اعلان
King Abdullah stressed the importance of the
pharmaceutical sector for the national economy, noting that pharmaceutical industries
are among the priority sectors of the Economic Modernization Vision for the
upcoming 10 years.
His Majesty
called for supporting the growth of pharmaceutical industries, streamlining
procedures related to the registration of medications, and mitigating any
obstacles that may face the sector.
The King
lauded
Hikma Pharmaceuticals as one of the leading national companies in the
pharmaceutical sector.
His Majesty
was briefed by Hikma’s Executive Vice Chairman and President of Hikma Mazen
Darwazah on the company’s future plans.
Darwazah said
the company plans to establish a regional research and development (R&D)
hub in Salt, which will enable the company to outsource R&D capabilities to
the region and the world.
The R&D
hub, expected to be completed in 2024, will strengthen the company’s global
position, he added, noting Hikma Pharmaceuticals operates 32 manufacturing
plants and seven major R&D centers in the US, Europe, and the MENA region,
including two in Jordan.
Darwazah said
Hikma currently contributes approximately 5 percent of Jordan’s total national
exports and nearly 75 percent of pharmaceutical exports, adding that it has a
10 percent share of the Jordanian pharmaceutical market and a $370 million
economic value flowing from it to the Jordanian economy
The executive
vice chairman said that in 2021, Hikma exported $392 million worth of
pharmaceutical products from Jordan to global markets, expecting exports to
grow in 2022 to surpass $465 million.
Prime Minister Bisher Al-Khasawneh, Royal Hashemite Court Chief Yousef Issawi, Health Minister Feras
Al-Hawari, and Hikma Pharmaceuticals Executive Chairman and CEO Said Darwazah
attended the visit.
Read more National news
Jordan News